Akums Drugs climbs on reporting 58% jump in Q1 consolidated net profit
Akums Drugs & Pharmaceuticals is currently trading at Rs. 736.20, up by 39.70 points or 5.70% from its previous closing of Rs. 696.50 on the BSE.
The scrip opened at Rs. 717.25 and has touched a high and low of Rs. 750.00 and Rs. 708.00 respectively. So far 50875 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 750.00 on 10-Aug-2026 and a 52 week low of Rs. 410.10 on 21-Jan-2026.
Last one week high and low of the scrip stood at Rs. 750.00 and Rs. 656.10 respectively. The current market cap of the company is Rs. 11411.06 crore.
The promoters holding in the company stood at 75.26%, while Institutions and Non-Institutions held 15.35% and 9.39% respectively.
Akums Drugs and Pharmaceuticals has reported marginal fall by 0.07% in its net profit at Rs 44.84 crore for the first quarter ended June 30, 2026 (Q1FY27) as compared to Rs 44.87 crore for the same quarter in the previous year. However, total income of the company has increased by 15.90% at Rs 418.38 crore for Q1FY27 as compared to Rs 361.00 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 57.55% jump in its net profit at Rs 100.01 crore for Q1FY27 as compared to Rs 63.48 crore for the same quarter in the previous year. The total income of the company has increased by 13.92% at Rs 1,197.01 crore for Q1FY27 as compared to Rs 1,050.76 crore for the corresponding quarter previous year.
